1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, June 2016 (p38)

Healthcare Analysis & Statistics, June 2016 (p38)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

1111-1140 of about 37 000 reports

Purchase Reports From Reputable Market Research Publishers

Baculoviral IAP Repeat-Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2016

Baculoviral IAP Repeat-Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Baculoviral IAP Repeat-Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Baculoviral IAP Repeat-Containing ...

  • Industries : Cancer, Therapy, Biopharmaceutical, Pathology, Biotechnology
  • Countries : United States
Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucin 1 (MUC-1 or Breast Carcinoma-Associated ...

  • Industries : Cancer, Therapy, Biopharmaceutical, Pathology, Biotechnology, Pharmaceutical
  • Countries : World, United States
Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 2016

Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Methionine Aminopeptidase 2 (MAP ...

  • Industries : Pathology, Pharmaceutical, Therapy
  • Countries : World, United States
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Pathology, Pharmaceutical, Chronic Disease, Therapy
  • Countries : United States
Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016

Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016’, ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : United States
Superoxide Dismutase [Cu-Zn](Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or EC 1.15.1.1) - Pipeline Review, H1 2016

Superoxide Dismutase [Cu-Zn](Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or EC 1.15.1.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Superoxide Dismutase [Cu-Zn](Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or EC 1.15.1.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Superoxide Dismutase [Cu-Zn](Superoxide ...

  • Industries : Pathology, Therapy, Mental Health, Pharmaceutical
  • Countries : United States
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Therapy, Biopharmaceutical, Biotechnology
  • Countries : United States
Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016

Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : Europe, World, United States
US Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

US Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume ...

  • Industries : In Vitro Diagnostics, Blood Supply, Tissue Banking and Transplantation, Pathology, Healthcare
Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : In Vitro Diagnostics
CA Tumor Markers: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

CA Tumor Markers: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : Diagnostics
Coagulation Testing in Hospitals, Private Labs, and POC Locations--Supplier Shares, Country Volume and Sales Forecasts

Coagulation Testing in Hospitals, Private Labs, and POC Locations--Supplier Shares, Country Volume and Sales Forecasts

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

This report provides a worldwide overview of the coagulation testing market, including estimates of facilities performing coagulation tests, as well as test volume and sales forecasts for coagulation reagents ...

  • Industries : In Vitro Diagnostics
  • Countries : World
HIV/AIDS Diagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

HIV/AIDS Diagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology ...

  • Industries : In Vitro Diagnostics
  • Countries : Europe, Japan
CMV: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

CMV: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology ...

  • Industries : In Vitro Diagnostics
  • Countries : Europe, Japan
Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016 ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States
Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016

Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States
Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) ...

  • Industries : In Vitro Diagnostics, Pathology, Pharmaceutical
  • Countries : United States
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology, Cancer, Pharmaceutical
  • Countries : United States
C5a Anaphylatoxin Chemotactic Receptor 1 (C5a Anaphylatoxin Chemotactic Receptor or C5a-R or CD88 or C5AR1) - Pipeline Review, H1 2016

C5a Anaphylatoxin Chemotactic Receptor 1 (C5a Anaphylatoxin Chemotactic Receptor or C5a-R or CD88 or C5AR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C5a Anaphylatoxin Chemotactic Receptor 1 (C5a Anaphylatoxin Chemotactic Receptor or C5a-R or CD88 or C5AR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C5a Anaphylatoxin Chemotactic ...

  • Industries : Pathology, Therapy
  • Countries : World
Apolipoprotein E (ApoE) - Pipeline Review, H1 2016

Apolipoprotein E (ApoE) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Apolipoprotein E (ApoE) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Apolipoprotein E (ApoE) - Pipeline Review, H1 2016’, provides in depth analysis on Apolipoprotein E (ApoE) targeted ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : United States
Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Pipeline Review, H1 2016

Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Pipeline Review, ...

  • Industries : Pathology, Pharmaceutical, Chronic Disease, Therapy, Drug Discovery and Development
  • Countries : World
Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Pipeline Review, H1 2016

Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : World
P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘P-Selectin (Granule ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : United States, World
Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Proprotein ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease, Pathology
  • Countries : United States
Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Pathology, Therapy, Cancer, Pharmaceutical
  • Countries : United States
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Pathology, Cancer, Therapy, Pharmaceutical
  • Countries : United States
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 2 (Transcriptional ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.